OpenArc Corporate Advisory Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$173M |
| 2 |
Vanguard Russell 1000 Value ETF
VONV
|
+$55.3M |
| 3 |
iShares MSCI EAFE Value ETF
EFV
|
+$54M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$34.1M |
| 5 |
BlackRock Flexible Income ETF
BINC
|
+$28.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BAI
iShares A.I. Innovation and Tech Active ETF
BAI
|
+$119M |
| 2 |
PWRD
TCW Transform Systems ETF
PWRD
|
+$57.9M |
| 3 |
iShares US Financial Services ETF
IYG
|
+$24.4M |
| 4 |
Roper Technologies
ROP
|
+$24.1M |
| 5 |
iShares US Consumer Staples ETF
IYK
|
+$16.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.24% |
| 2 | Consumer Discretionary | 5.63% |
| 3 | Healthcare | 3.98% |
| 4 | Industrials | 3.9% |
| 5 | Communication Services | 3.21% |
Similar funds
OpenArc Corporate Advisory's Q2 2026 Portfolio in Review
As of Q2 2026, OpenArc Corporate Advisory held 833 positions worth $8.41B, up 20% from $6.98B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
OpenArc Corporate Advisory deployed $539M of net new capital in Q2 2026, opening 117 new positions and adding to 380 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 437,245 shares worth $179M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was iShares A.I. Innovation and Tech Active ETF, an estimated $119M trimmed.
- OpenArc Corporate Advisory's largest Q2 2026 buy was iShares Russell 1000 ETF: 437,245 shares worth $179M.
- OpenArc Corporate Advisory added most to Vanguard Russell 1000 Value ETF in Q2 2026, an estimated $55.3M increase.
- OpenArc Corporate Advisory's biggest Q2 2026 reduction was iShares A.I. Innovation and Tech Active ETF, cutting an estimated $119M.
- OpenArc Corporate Advisory fully exited Kiniksa Pharmaceuticals in Q2 2026, selling an estimated $2.33M.
- OpenArc Corporate Advisory's ten largest holdings make up 33% of its $8.41B portfolio in Q2 2026.
- OpenArc Corporate Advisory opened 117 new positions and closed 44 in Q2 2026.
- OpenArc Corporate Advisory's portfolio value rose 20% quarter-over-quarter to $8.41B.
Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.